MyHealthChecked PLC Health Inspectorate Wales registration

TIDMMHC

MyHealthChecked PLC

03 May 2023

MyHealthChecked PLC

( " MyHealthChecked " or the "Company " )

Health Inspectorate Wales registration

Registration for MyHealthChecked's tests demonstrate compliance with national standards

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that it has received a Notice of Decision confirming that MyHealthChecked is now registered with the Healthcare Inspectorate Wales ('HIW'). To achieve this status, MyHealthChecked has gone through a rigorous process to ensure that all of the Company's processes are compliant with national regulatory standards in Wales in relation to oversight of test results, and the provision of phlebotomy services.

Healthcare Inspectorate Wales ( https://www.hiw.org.uk/ ) is the independent inspector and regulator of all healthcare in Wales (NHS and independent healthcare providers). Being registered with HIW provides MyHealthChecked's customers with assurance that the Company is performing to the highest standards of compliance, as agreed by an organisation that is independent, fair and evidence driven, and committed to taking action to improve poor standards, whilst also recognising good practice. It also provides confidence to MyHealthChecked customers that the Company is independently regulated and will provide safe, timely and good quality care and the needs of customers are prioritised.

Registration with HIW is essential for MyHealthChecked to provide doctor oversight for MyHealthChecked blood and blood/urine tests, as well as enabling it to offer phlebotomy services through B2B retail partners. The Registration covers all the tests in MyHealthChecked's new product portfolio.

Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, said: " Receiving this accreditation from Healthcare Inspectorate Wales provides MyHealthChecked and our partners with the assurance that we are deemed to be operating to the highest standards. This registration from an independent body also further validates the quality of our at-home wellness testing service and our commitment to patient care. This is an essential precursor to any nationwide launch of the products into a retail partner."

For further information contact:

 
 MyHealthChecked PLC                                                www.myhealthchecked.com 
 Penny McCormick, Chief Executive                                           via Walbrook PR 
  Officer 
 
 SPARK Advisory Partners Limited                                   Tel: [phone] 
  (NOMAD) 
 Neil Baldwin 
 
 Dowgate Capital Limited (Broker)                                  Tel: [phone] 
 David Poutney / Nicholas Chambers 
 
 Walbrook PR Ltd (Media       Tel: [phone] or [e-mail] 
  & IR) 
 Paul McManus / Alice Woodings                               Mob: [phone] / +44 
                                                                            (0)7407 804 654 
 
 

About MyHealthChecked PLC ( https://investors.myhealthchecked.com/ )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests will also be made available online and will be viable for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRADZGGKGZFGFZZ

(END) Dow Jones Newswires

May 03, 2023 02:00 ET (06:00 GMT)